tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Organogenesis Holdings Approves Key Proposals at Annual Meeting
PremiumCompany AnnouncementsOrganogenesis Holdings Approves Key Proposals at Annual Meeting
21d ago
Buy Rating for Organogenesis: Favorable Medicare Pricing and Attractive Valuation Signal Growth Potential
Premium
Ratings
Buy Rating for Organogenesis: Favorable Medicare Pricing and Attractive Valuation Signal Growth Potential
1M ago
Hold Rating Maintained for Organogenesis Holdings Amid Uncertainty in Coverage and Sales Projections
Premium
Ratings
Hold Rating Maintained for Organogenesis Holdings Amid Uncertainty in Coverage and Sales Projections
2M ago
CMS reviewing coverage policies for skin substitute products
PremiumThe FlyCMS reviewing coverage policies for skin substitute products
3M ago
Organogenesis Highlights Strategic Focus in Investor Presentation
Premium
Company Announcements
Organogenesis Highlights Strategic Focus in Investor Presentation
4M ago
Organogenesis price target raised to $6 from $4 at Morgan Stanley
Premium
The Fly
Organogenesis price target raised to $6 from $4 at Morgan Stanley
4M ago
Organogenesis sees FY25 revenue $480M-$535M, consensus $472.94M
PremiumThe FlyOrganogenesis sees FY25 revenue $480M-$535M, consensus $472.94M
5M ago
Organogenesis reports Q4 EPS 4c, consensus 2c
Premium
The Fly
Organogenesis reports Q4 EPS 4c, consensus 2c
5M ago
Organogenesis files to sell 130K shares of common stock for holders
Premium
The Fly
Organogenesis files to sell 130K shares of common stock for holders
7M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100